SNY/REGN—FDA approves Dupixent for eosinophilic esophagitis: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-eosinophilic-esophagitis-chronic-immune-disorder This the first FDA-approved drug for the indication.